All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Recurrent Childhood Soft Tissue Sarcoma | NCIT_C8067 | [The reemergence of soft tissue sarcoma in childhood after a period of remission.] |
| Childhood Rhabdomyosarcoma | NCIT_C7705 | [An aggressive malignant mesenchymal neoplasm arising from skeletal muscle in children. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.] |
| Childhood Craniopharyngioma | NCIT_C7816 | [A craniopharyngioma that occurs during childhood. The vast majority of cases are adamantinomatous craniopharyngiomas. Clinical signs and symptoms include endocrine deficiencies and visual disturbances.] |
| Craniopharyngioma | NCIT_C2964 | [A benign, partly cystic, epithelial tumor of the sellar region, presumably derived from Rathke pouch epithelium. It affects mainly children and young adults. There are two clinicopathological forms: adamantinomatous craniopharyngioma and papillary craniopharyngioma. The most significant factor associated with recurrence is the extent of surgical resection, with lesions greater than 5 cm in diameter carrying a markedly worse prognosis. (Adapted from WHO)] |
| Adult Synovial Sarcoma | NCIT_C7817 | [A synovial sarcoma occurring in adults.] |
| Synovial Sarcoma | NCIT_C3400 | [A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11). It can occur at any age, but mainly affects young adults, more commonly males. Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee. Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components). Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.] |
| Performed Protocol Deviation Date Range | NCIT_C93960 | [The date and time span specifying when the protocol deviation began and ended.] |
| Performed Specimen Collection Fasting Status Indicator | NCIT_C93961 | [Specifies whether the participant had abstained from eating when the specimen is obtained.] |
| Fasting Status Indicator | NCIT_C93566 | [Specifies whether the subject has abstained from food and possibly water for the prescribed amount of time.] |
| Performed Study Agent Transfer Original Quantity | NCIT_C93962 | [The amount and unit of study agent transferred in original units.] |
| Original Quantity | NCIT_C93614 | [The amount, including units, of something as first specified.] |
| Increased Drug Level | NCIT_C54355 | [A laboratory test result demonstrating an increased concentration of a specific drug.] |
| Pharmacokinetic Effect Consequences | NCIT_C54354 | [The outcome that results from chemical interactions between a drug and another drug or food.] |
| Drug Level Test Result | NCIT_C54359 | |
| Performed Study Agent Transfer Quantity | NCIT_C93963 | [The amount and unit of study agent transferred in standard or canonical units.] |
| Decreased Drug Level | NCIT_C54356 | [A reduction in the expected therapeutic effect of a drug due to increased clearance.] |
| Performed Study Subject Milestone Informed Consent Date | NCIT_C93964 | [The date (and time) the study subject gives official consent by signing the official consent form.] |
| Informed Consent Date | NCIT_C93579 | [The date (and time) the patient gives consent to a surgical or medical procedure or participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved.] |
| Increased Concomitant Drug Level | NCIT_C54357 | |
| Performed Study Subject Milestone Off Study Date | NCIT_C93965 | [The date (and time) when the study subject is removed from the study.] |